Neoantigen × AI
Daily research signal
24Brief

TCR-T cells kill Ewing sarcoma via public neoantigens

Preclinical data demonstrates that TCR-T cells targeting public, EWSR1::FLI1-driven neogene-encoded antigens can specifically kill Ewing sarcoma cells in vivo without off-target effects.bioRxiv

This approach offers a potential therapeutic avenue for relapsed or resistant Ewing sarcoma patients with limited options.

1new story
Clinical3 days agoNew

Specific killing of Ewing sarcoma by TCR-T cells targeting public neogene-encoded antigens

Researchers identified neogenes (Ew_NGs) induced by the EWSR1::FLI1 fusion in Ewing sarcoma, which present peptides on HLA-I complexes. CD8+ T cells specific to these public antigens killed EwS cells in an HLA-I restricted manner, a process dependent on both the fusion and the neogene expression. Transduced TCR-T cells replicated this cytotoxicity in vivo without off-target or allogeneic activation, suggesting a viable cell therapy for relapsed/resistant cases.

biorxiv · 3 days ago · Lalanne, A. I.; Collin, C.; Petit, F.; Lacaud, M.; Arribas, Y. A.; Darbois Delahousse, A.;